BioSpace News Archive

Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD).

AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference,

Clarametyx Biosciences Inc. today announced the receipt of a grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) at the National Institutes of Health (NIH) for up to $3.15 million over three years.

Seagen Inc. announced that management will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 3:00 p.m. Eastern Time.

Kriya Therapeutics, Inc. today announced the appointment of Neera Ravindran, M.D., M.B.A., as Chief Financial Officer.

Twist Bioscience Corporation today announced the launch of the Twist 96-Plex Library Prep Kit, a high-performance, cost-effective preparation kit for next-generation sequencing (NGS).

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) today announced it has extended a licensing and collaboration agreement with the National Research Council of Canada (NRC) that will enable Oragenics to pursue an intranasal vaccine designed to protect against the SARS-CoV-2 Omicron variant.

bluebird bio, Inc . (NASDAQ: BLUE) today announced that the FDA has placed its clinical program for lovotibeglogene autotemcel (lovo-cel) gene therapy for sickle cell disease (SCD) on partial clinical hold for patients under the age of 18.

CG Oncology, Inc. announced today it has triggered the first development milestone payment under its licensing agreement with Kissei Pharmaceutical Co., Ltd. for its oncology immunotherapy CG0070 for Japan South Korea, Taiwan and other Asian countries with the exception of China.

ImmunoPrecise Antibodies and ChemPartner Biologics Announce PolyTope ® TATX-03 Antibody Cocktail Manufacturing Collaboration.